Fingolimod vs dimethyl fumarate in multiple sclerosis

Abstract

This study provides Class IV evidence that for patients with RRMS, DMF and FNG have comparable efficacy in treatment-naive patients and that FNG is superior to DMF in patients switching from self-injectable drugs.